3SOF

Should be another high volume day......

Sorry guys I did not know that this thread existed

Patience now has been rewarded. Added 5k yesterday.

Great News:Generex Biotechnology to Accelerate Development of Vaccine for Pandemic Avian Influenza
http://biz.yahoo.com/iw/051019/098453.html

The Vaccine for Pandemic Avian Influenza alone should push the sp to at least 10$,
it´s just a matter of time.

JMHO.

Strong buy.

Good luck to all the longs

Below is a 3-year chart.  With record volume, historically low price and super-relevant news, this could easily make it's way back to upper $1's to $2.00 in short-term.

Hit the wrong button.  Here's the post with the 3-year chart.

Below is a 3-year chart.  With record volume, historically low price and super-relevant news, this could easily make it's way back to upper $1's to $2.00 in short-term.

Troubles with connection this morning
Opened a position in this . Let's rock and roll guys and gals!

It closed with 17 mil shares traded and lower than its open 1.09 to 1.00. HOD was 1.21.

Repeated yesterday's act. Last time it repeated this stock pattern it crashed 3rd day...

Lets see what comes up tomorrow. One thing their main product inhaler insulin will be hot.... ( Inhaler insulin) Sanofi, Pfizer and Nektar are working on it also....

Nice pullback... good for re-entry point...it closed that gap from yesterday

Keep an eye on it, it's starting to run again.

Had a real strong close, I think we'll see a nice run next weak. There will be a lot of bird flu news this weakend. And the presentation will probally give it some upside.

TORONTO--(MARKET WIRE)--Oct 21, 2005 -- Generex Biotechnology Corporation (NasdaqSC:GNBT - News), a leader in the area of buccal drug delivery, today announced that Dr. Jaime Guevara-Aguirre, of the Institute of Endocrinology IEMYR in Quito, Ecuador, and one of the principal investigators in the Company's on-going clinical trials of Oral-lyn(TM), its proprietary oral insulin spray product, will make the following presentation of Oral-lyn(TM) clinical trial results at the 6th International Diabetes Federation Western Pacific Region Congress to be held in Bangkok, Thailand, from October 22 - 26, 2005:



"A 12-Day Comparison of Preprandial Humulin® vs. Oral-lyn(TM) in 10 Type 1 Diabetic Subjects Receiving Baseline Glargine Insulin Therapy," scheduled for oral presentation on October 24, 2005. The study is coauthored by Marco Guevara and Jeannette Saavedra.

Generex subsidiary accelerates development of bird flu vaccine

Friday , October 21, 2005 13:00 ET

Oct 21, 2005 (Datamonitor via COMTEX) --Antigen Express, a subsidiary of Generex Biotechnology Corporation, has re-organized its forces to speed development of a novel vaccine to protect against the H5N1 avian influenza.

In particular, Generex has announced that the president of Antigen Express, Eric von Hofe, will focus his efforts and those of the company on bringing this new vaccine into the clinic in the shortest time possible.

A similar vaccine peptide, designed using a portion of a protein expressed in breast cancer cells modified with Ii-Key, is currently in clinical trials at the Walter Reed Army Medical Center.

"The threat of a pandemic by avian influenza has made it clear that yesterday's vaccine technologies are woefully insufficient," said Mr von Hofe. "The vaccines being developed at Antigen Express have a clear role to play in responding to threats posed by agents such as H5N1 influenza."

If an avian flu epidemic were to break out amongst humans current vaccine development methods would be likely to be insufficient to supply the world's need for such a vaccine. According to Generex, current estimates are that the total production capacity of the world for producing an avian flu vaccine using traditional methods is less than 40 million doses, at the cost of several 100 million dollars.

A compounding problem in developing vaccines for the avian flu is that two doses are required to achieve protective immunity given that people have never been exposed to a flu virus similar enough to impart even partial immunological protection.

Look at the long term chart ... is not that nice?  it breaks the long term downtrend 

Just started to run,keep an eye on it.

GNBT what do i see.. I need a cup of coffee  it might be 

Bird FLU stocks will be on fire again today, GNBT is making a move in PRE MKT. Keep an eye on this one. This could be the next NVAX.